Vice President, Global Program Lead - Hematology Late Development

Working with UsChallenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.Position Summary:The Global Program Lead (GPL) will serve as the “point of accountability” for two hematology assets. The program includes a growing marketed asset for anemia with ongoing pivotal studies and a potential first in class CELMoD for sickle cell disease. The GPL role is accountable for leading the Global Program Teams and orchestrating the design and execution of a global integrated program strategy from candidate nomination through drug development to successful launch and commercialization. The GPL develops, leads, and inspires a high performing matrix. They are responsible for cross-functional stakeholder relationships and input to ensure end to end understanding of upstream and downstream alignment and business implications for the strategy, and its evolution as emerging data and competitive insights unfold. In addition to leading these programs, the GPL will play a key role in the related disease area strategies (e.g., AML).Technical/Functional Responsibilities: Develops and manages product strategy and drug development programs to ensure approval and commercial successDefines and executes the strategic integrated development plan (IDP) in partnership with the cross functional GPT membersParticipates in regulatory filings (NDA, BLA filings), engaging with Health Authorities and/or Advisory CommitteesLeads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial designBuilds and maintains collaborative relationships with external stakeholders and appropriately incorporates insights and advice to maximize program impactActively supports Investor Relations and Public Affairs in managing external BMS communicationsIntegrates commercialization inputs and deliverables to design the program strategy that enables approval of meaningfully differentiated assets with potential to maximize asset valueUnderstands necessary commercial inputs needed to inform the end-to-end development process leading to regulatory approval and successful commercialization Integrates market inputs into the integrated development plan, including clinical plans and labeling strategy; Appreciates translation of clinical data into claims and considerations for label developmentUnderstands and contributes to development of forecasts and investment scenarios, how to assess risk and conduct valuations, and implications for decision makingContributes to the development of brand hallmarks and brand strategy, understanding the relationship to clinical trial designIn partnership with Medical Affairs, supports development of KOL plans and engagements, and leverages KOL input in context of development programs and communicating evidenceSupports commercial needs and recommendations to guide CMC and GPS on trade packaging and commercial productClinical Trial Design, Execution, and InterpretationUtilizes various resources to design clinical trials that are competitively differentiatingActively participates with Health Authorities in finalizing clinical design and adequate endpointsUnderstands clinical trial operational complexities from study start up through enrollment, quality assurance, and study readoutHas an active role in analysis and/or interpretation of clinical data and translation into scientific communication strategy, including publications, and commercial strategyUnderstands and reflects the impact of value and access inputs and value drivers in clinical trial designLeadership ResponsibilitiesInclusively Collaborates Across the BMS Matrix with an Enterprise Mindset: Effectively collaborates with matrix functions by building trust and driving toward the collective success of the programDemonstrates Enterprise Mindset Problem-Solving and Decision Making: Gathers diverse perspectives assess alternate resolutions and makes thoughtful, informed Enterprise decisionsDevelops and Leads a High Performing Matrix Team: Builds, leads and inspires high performing cross functional matrix team through a unified program strategy on behalf of our patientsHolds Oneself and Others Accountable: Takes initiative to address challenges, removes barriers, holds others accountable for the collective success of the program outcomes and team collaborationDemonstrates Character: Leads with the values, self-awareness, and humility, seeks feedback, Includes integrityQualifications: (core requirement - mandatory) BS/BA required, and an advanced degree preferred (MD, PhD, MBA, PharmD, etc.)Must have experience in the drug development processProven demonstrated leadership capability; previous experience in building and leading a high performing teamA minimum of 10 years in the drug development & commercialization process with proven progression in relevant rolesSignificant experience in related therapeutic areaAdditional requirements:Extensive working knowledge in the end-to-end drug development process, along with expertise in one or more of the relevant areasPrior experience